These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16557993)

  • 41. In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.
    Chaudhari CN; Tandel K; Grover N; Bhatt P; Sahni AK; Sen S; Prahraj AK
    Med J Armed Forces India; 2014 Jul; 70(3):215-9. PubMed ID: 25378772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
    Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
    J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Light and scanning-beam electron microscopy of wall-defective Staphylococcus aureus induced by lysostaphin.
    Watanakunakorn C; Fass RJ; Klainer AS; Hamburger M
    Infect Immun; 1971 Jul; 4(1):73-8. PubMed ID: 4949481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics.
    Zygmunt WA; Harrison EF; Browder HP; Tavormina PA
    Appl Microbiol; 1968 Aug; 16(8):1174-8. PubMed ID: 5187926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lysostaphin-induced, osmotically fragile Staphylococcus aureus cells.
    Huber TW; Schuhardt VT
    J Bacteriol; 1970 Jul; 103(1):116-9. PubMed ID: 5423366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
    Boyle-Vavra S; Carey RB; Daum RS
    J Antimicrob Chemother; 2001 Nov; 48(5):617-25. PubMed ID: 11679550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.
    Gründling A; Schneewind O
    J Bacteriol; 2006 Apr; 188(7):2463-72. PubMed ID: 16547033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.
    McDougal LK; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):482-8. PubMed ID: 6562125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
    Jones RN; Barry AL; Gardiner RV; Packer RR
    Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP; Gemmell CG; Coote PJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Staphylococcus aureus mutants with increased lysostaphin resistance.
    Gründling A; Missiakas DM; Schneewind O
    J Bacteriol; 2006 Sep; 188(17):6286-97. PubMed ID: 16923896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative.
    Bobin-Dubreux S; Reverdy ME; Nervi C; Rougier M; Bolmström A; Vandenesch F; Etienne J
    Antimicrob Agents Chemother; 2001 Jan; 45(1):349-52. PubMed ID: 11120996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
    Koehl JL; Muthaiyan A; Jayaswal RK; Ehlert K; Labischinski H; Wilkinson BJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3749-57. PubMed ID: 15388430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sensitivity of the Staphylococcus to the effect of bacitracin, soframycin, novobiocin, cycloserine, vancomycin, ristocetin and kanamycin].
    WLODARCZAK K; JELJASZEWICZ J
    Postepy Hig Med Dosw; 1960; 14():101-3. PubMed ID: 13845537
    [No Abstract]   [Full Text] [Related]  

  • 59. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
    Sader HS; Fritsche TR; Jones RN
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The change in sensitivity of methicillin-resistant Staphylococcus aureus to vancomycin].
    Ma Y; Chen H; Yao L; Li J; Zhang L; Hu C; Jin S
    Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):31-3. PubMed ID: 11940294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.